Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Patient Preference × apalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Small Cell Lung Carcinoma 1 Prostate Adenocarcinoma 1 Patient Preference 1 Carcinoma, Small Cell 1 Bulbo-Spinal Atrophy, X-Linked 1

Interventions

enzalutamide 1 apalutamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04409288 2024-01-05

Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer

Chinese University of Hong Kong

Phase 3 Terminated

Prostatic Neoplasms, Patient Preference

Data powered by HemOnc (CC BY 4.0) Colophon ⚡